If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Email*

Password*

Keep me logged in Forgot your password?

Email*

Hemodialysis

High, Low PTH Raises Hypercalcemia Risk

Jody A. Charnow May 13, 2012

NATIONAL HARBOR, Md.—Low and high levels of parathyroid hormone (PTH) are associated with hypercalcemia, according to a study of 106,760 hemodialysis patients presented at the National Kidney Foundation 2012 Spring Clinical Meetings suggest.

Peginesatide Requirements Do Not Differ By Race

Jody A. Charnow May 13, 2012

NATIONAL HARBOR, Md.—Black hemodialysis (HD) patients with anemia require relatively more epoetin than their non-black counterparts to achieve similar hemoglobin (Hb) levels, but blacks and non-blacks required similar peginesatide doses, according to findings presented at the National Kidney Foundation 2012 Spring Clinical Meetings.

Labs May Vary in iPTH Measurements

Jody A. Charnow May 12, 2012

NATIONAL HARBOR, Md.—Laboratories can differ in their measurements of intact parathyroid hormone (iPTH) levels, resulting in varying treatment approaches for hemodialysis (HD) patients depending on the iPTH assay used, researchers reported at the National Kidney Foundation Spring Clinical Meetings.

PCa Patients on HD Would Benefit from Early Kidney Transplantation

Jody A. Charnow May 12, 2012

NATIONAL HARBOR, Md.—Hemodialysis (HD) patients awaiting a kidney transplant must have a two-year cancer-free period immediately preceding transplantation.

Higher Alkaline Phosphatase Raises Death Risk in HD Patients

Jody A. Charnow May 12, 2012

NATIONAL HARBOR, Md.—Elevated levels of serum alkaline phosphatase are associated with decreased long-term survival among hemodialysis (HD) patients, data presented at the National Kidney Foundation 2012 Spring Clinical Meetings suggest.

Calcitriol as Effective as Vitamin D Analogues, but Cheaper

Jody A. Charnow May 11, 2012

NATIONAL HARBOR, Md.—Oral calcitriol is as effective as vitamin D analogues for treating secondary hyperparathyroidism (SHPT) in hemodialysis patients but is more cost effective, according to a study presented at the National Kidney Foundation 2012 Spring Clinical Meetings.

Study: Phosphate Binder Noncompliance Underreported

Jody A. Charnow May 11, 2012

NATIONAL HARBOR, Md.—Dialysis patient underreporting of noncompliance with phosphate binder therapy may contribute to poor phosphorus control, investigators reported at the National Kidney Foundation 2012 Spring Clinical Meetings.

Novel Iron-Based Phosphate Binder Effective, Well-Tolerated

Jody A. Charnow May 11, 2012

NATIONAL HARBOR, Md.—An investigational iron-based phosphate binder is effective and well tolerated in hemodialysis (HD) patients with hyperphosphatemia, according to data presented at the National Kidney Foundation 2012 Spring Clinical Meetings.

Black Home HD Patients More Likely to Return to In-Center HD

Jody A. Charnow May 11, 2012

NATIONAL HARBOR, Md.—Black home hemodialysis (HD) patients are more likely than their white counterparts to return to in-center HD, according to data presented at the National Kidney Foundation 2012 Spring Clinical Meetings.

X-Rays Unreliable for Diagnosing Pneumonia in HD Patients

Jody A. Charnow May 11, 2012

NATIONAL HARBOR, Md.—Chest X-rays are unreliable for diagnosing pneumonia in hemodialysis (HD) patients, researchers reported at the National Kidney Foundation 2012 Spring Clinical Meetings.

Hemoglobin Trends Change in Wake of Bundling

Jody A. Charnow May 11, 2012

NATIONAL HARBOR, Md.—Researchers have found that hemoglobin levels in dialysis patients have changed since implementation of the bundled payment system for dialysis services in January 2011, according to a report presented at the National Kidney Foundation 2012 Spring Clinical Meetings.

IV Iron Drugs Not Equal in Hemoglobin Response

Jody A. Charnow May 11, 2012

NATIONAL HARBOR, Md.—In a recently completed clinical trial, treatment with ferumoxytol resulted in a greater hemoglobin (Hb) response than iron sucrose in hemodialysis (HD) patients with anemia and non-dialysis patients with severe anemia, researchers reported at the National Kidney Foundation 2012 Spring Clinical Meetings.

Higher CV Event Rate Linked to Low Hb in HD Patients

Jody A. Charnow May 11, 2012

NATIONAL HARBOR, Md.—Hemodialysis (HD) patients receiving either epoetin or peginesatide who achieve low hemoglobin (Hb) levels have an increased rate of cardiovascular (CV) events, according to new data presented at the National Kidney Foundation 2012 Spring Clinical Meetings.

Implantable Artificial Kidney Advances

John Schieszer May 08, 2012

An implantable artificial kidney is moving closer toward reality.

Early Dialysis Starts Associated with Worse Outcomes

Rosemary Frei, MSc May 07, 2012

This approach is associated with an increased likelihood of withdrawal from treatment, study finds.

Estradiol Levels Affect Death Risk Among Women on HD

Jody A. Charnow May 02, 2012

High and low serum estradiol levels in women on hemodialysis (HD) are associated with increased overall and cardiovascular mortality, according to researchers.

Hospitalization Risk for Infections Higher with PD

Rosemary Frei, MSc April 30, 2012

ST. JOHN'S, NEWFOUNDLAND—Patients on peritoneal dialysis (PD) are at 51% higher risk of being hospitalized for infections than those receiving hemodialysis (HD), according to findings presented at the Canadian Society of Nephrology annual meeting.

Kidney Disease Leaders Recommend Ways to Expand Home Dialysis Use

Stephan Cho April 30, 2012

Leaders in the dialysis community have released a report that outlines key findings and recommendations for better utilization of home dialysis as an alternative to in-center treatment.

Safest Hemodialysis Vascular Access Options Unclear

Rosemary Frei, MSc April 28, 2012

ST. JOHN'S, NEWFOUNDLAND—Central venous catheters (CVCs) are associated with the highest mortality risk among hemodialysis (HD) vascular access options, according to a systematic literature review presented at the Canadian Society of Nephrology's 2012 annual meeting. Arteriovenous grafts confer the second-highest risk for mortality, followed by native arteriovenous fistulas (AVFs).

Antimicrobial Locks in HD Catheters May Have a Down Side

Jody A. Charnow April 20, 2012

Antimicrobial locks (AML) decrease the incidence of catheter-related bloodstream infections in hemodialysis (HD) patients, but they may result in the emergence of problematic pathogens, according to British investigators.

Daily Home Dialysis Improves Survival

John Schieszer April 17, 2012

Daily home dialysis may provide a better quality of life and lower a patient's risk of dying compared with conventional dialysis treatments.

Dialysis May Help Some Patients with Treatment-Resistant CHF

Jody A. Charnow April 11, 2012

Dialysis may improve outcomes in patients suffering from treatment-resistant congestive heart failure (CHF) accompanied by severe renal insufficiency, new findings suggest.

Setting Up a Home Hemodialysis Program

Joel D. Glickman, MD April 01, 2012

As you develop and grow a home HD program, not only will you have wonderful successes, but there will also be challenges and disappointments.

HD Is An Independent Risk Factor for Atherosclerosis

Jody A. Charnow April 01, 2012

Hemodialysis (HD) is an independent risk factor for atherosclerosis in patents who have chronic renal failure (CRF).

Technique Treats Central Venous Occlusion in Dialysis Patients

John Schieszer March 29, 2012

SAN FRANCISCO—A radiofrequency (RF) wire technique appears to be a safe alternative for managing benign chronic central venous occlusions when conventional techniques have failed, according to findings presented at the 37th Annual Scientific Meeting of the Society of Interventional Radiology.

No Need to Stop Clopidogrel for Catheter Procedures

Jody A. Charnow March 28, 2012

SAN FRANCISCO—Patients can safely continue on clopidogrel therapy while undergoing percutaneous tunneled catheter procedures, researchers reported at the 37th Annual Scientific Meeting of the Society of Interventional Radiology.

FDA Clears Once-Monthly Drug for Anemia in Dialysis Patients

Jody A. Charnow March 27, 2012

The FDA has approved peginesatide (Omontys) for the treatment of anemia in adult dialysis patients.

Researchers Report Success with Lumbar HD Catheters

John Schieszer March 27, 2012

SAN FRANCISCO—Translumbar hemodialysis catheters (THCs) are safe and may offer an effective vascular access route for hemodialysis (HD) patients with limited venous access options, even in overweight patients, according to data presented at the 37th Annual Scientific Meeting of the Society of Interventional Radiology.

The Impact of Bundling on Clinical Practice

Jay B. Wish, MD March 22, 2012

This is the title of a scheduled May 12 session (3:30-5:00 p.m.) at the National Kidney Foundation's 2012 Spring Clinical Meetings, which is being held at the Gaylord National in National Harbor, Md., May 9-13.